0001798639-20-000003.txt : 20200914 0001798639-20-000003.hdr.sgml : 20200914 20200911213741 ACCESSION NUMBER: 0001798639-20-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200914 DATE AS OF CHANGE: 20200911 EFFECTIVENESS DATE: 20200914 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEBUT BIOTECHNOLOGY, INC. CENTRAL INDEX KEY: 0001798639 IRS NUMBER: 841804621 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-375378 FILM NUMBER: 201172070 BUSINESS ADDRESS: STREET 1: 6330 NANCY RIDGE DR. UNIT 106 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (619) 432-5177 MAIL ADDRESS: STREET 1: 6330 NANCY RIDGE DR. UNIT 106 CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001798639 DEBUT BIOTECHNOLOGY, INC. 6330 NANCY RIDGE DR. UNIT 106 SAN DIEGO CA CALIFORNIA 92121 (619) 432-5177 DELAWARE None None Corporation true 2019 Joshua Britton 6330 Nancy Ridge Drive, Unit 106 San Diego CA CALIFORNIA 92121 Executive Officer Director Cain A. McClary 6330 Nancy Ridge Drive, Unit 106 San Diego CA CALIFORNIA 92121 Director Other Technology Decline to Disclose 06b false 2020-09-04 false true true true true Subordinated Convertible Promissory Note and the shares of Preferred or Common Stock issuable upon conversion. false 0 2700000 2200000 500000 false 7 0 0 0 false DEBUT BIOTECHNOLOGY, INC. Joshua Britton Joshua Britton Chief Executive Officer 2020-09-11